The researchers used a machine-learning algorithm to spot symptom patterns in the health records of nearly 35,000 U.S. patients who tested positive for SARS-CoV-2 infection and later developed lingering long-COVID-type symptoms.
The funding will support preliminary disease-related research, in the latest in a series of efforts to create new opportunities for interdisciplinary research.
Celebrating graduation and each other, students in the Executive Master of Health Administration and Executive Master of Public Administration programs at the Cornell Jeb E. Brooks School of Public Policy received diplomas at a joyful ceremony in Willard Straight Hall.
An artificial intelligence algorithm can determine non-invasively, with about 70% accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell Medicine.
A new generation of effective weight loss drugs is now available in the U.S., but the drugs’ high cost highlights a reality hurting the nation’s economy and those who want to shed pounds: Obesity is expensive, and so are the treatments.
Those already pregnant at the beginning of the pandemic had a 50% lower exposure to SARS-CoV-2 compared with those who became pregnant after the pandemic began and the general population, Weill Cornell researchers and colleagues found.
Cornell researchers found a link between the rate of ultrasonic vocalizations in mouse pups and their activity levels, which is important for understanding mouse models of communication disorders, including autism spectrum disorder.
An experimental therapy showed promise as treatment for an aggressively spreading type of colorectal cancer in preclinical models, according to a new study by Weill Cornell Medicine investigators.
Weill Cornell Medicine has been awarded a five-year, $7.8 million grant from the National Heart, Lung, and Blood Institute to study whether the antibiotic doxycycline may slow the progression of emphysema in people living with well-controlled HIV.